Teladoc Health (TDOC) Stock Price, News & Analysis

Company Overview

Teladoc Health, Inc. is a virtual healthcare company that provides telehealth services and technology to individuals, employers, health plans, health systems and other organizations. Its platform enables patients to connect with healthcare professionals remotely through phone, video and digital tools, supporting access to medical care across a range of specialties.

The company’s offerings include general medical consultations, mental health services through BetterHelp, expert medical opinions, chronic condition management and digital health programs. Teladoc also provides connected-care and data-driven solutions designed to help manage conditions such as diabetes, hypertension and weight-related health concerns. Its Livongo business, acquired in 2020, expanded the company’s capabilities in chronic care and remote patient support.

Founded in 2002, Teladoc has expanded from a U.S.-focused telehealth provider into a global virtual care company serving users and organizations in the United States and international markets. Its services are delivered through a combination of clinicians, digital platforms and health-management programs, with availability varying by product, customer and geography.

Key Stats

• Today's Range: $6.22 to $6.38
• 50-Day Range: $6.08 to $9.74
• 52-Week Range: $4.40 to $9.89
• Volume: 2.99 million shs
• Average Volume: 3.21 million shs
• Market Capitalization: $1.14 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $7.54
• Consensus Rating: Hold

Teladoc Health Stock Analysis - MarketRank™

Teladoc Health scored higher than 53% of companies evaluated by MarketBeat, and ranked 429th out of 898 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.6 / 5
• Analyst Rating: Hold

Consensus Rating

Teladoc Health has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on no strong buy ratings, 5 buy ratings, 10 hold ratings, and 1 sell rating.

Upside Potential

Teladoc Health has a consensus price target of $7.54, representing about 20.4% upside from its current price of $6.26.

Amount of Analyst Coverage

Teladoc Health has only been the subject of 4 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Teladoc Health are expected to grow in the coming year, from ($0.92) to ($0.76) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Teladoc Health is -6.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Teladoc Health is -6.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Teladoc Health has a P/B Ratio of 0.80. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

14.05% of the float of Teladoc Health has been sold short.

Short Interest Ratio / Days to Cover

Teladoc Health has a short interest ratio ("days to cover") of 7.17.

Change versus previous month

Short interest in Teladoc Health has recently increased by 6.98%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Teladoc Health does not currently pay a dividend.

Dividend Growth

Teladoc Health does not have a long track record of dividend growth.

News and Social Media

• Score: 2.6 / 5
• News Sentiment: 0.14

News Sentiment

Teladoc Health has a news sentiment score of 0.14. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.51 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 11 news articles for Teladoc Health this week, compared to 8 articles on an average week.

Search Interest

Only 3 people have searched for TDOC on MarketBeat in the last 30 days. This is a decrease of -25% compared to the previous 30 days.

MarketBeat Follows

4 people have added Teladoc Health to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

Company Ownership

• Score: 1.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Teladoc Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $108,610.00 in company stock.

Percentage Held by Insiders

0.70% of the stock of Teladoc Health is held by insiders.

Percentage Held by Institutions

76.82% of the stock of Teladoc Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 7/29/2026
• Today: 9/22/2026
• Next Earnings (Estimated): 10/28/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Healthcare
• Industry: Healthcare Technology
• Sub-Industry: Healthcare Technology
• Current Symbol: NYSE:TDOC
• CIK: 1477449
• Web: www.teladochealth.com
• Phone: (203) 635-2002
• Fax: N/A
• Employees: 5,600
• Year Founded: 2002

Price Target and Rating

• Average Price Target for Teladoc Health: $7.54
• High Price Target: $11.00
• Low Price Target: $5.00
• Potential Upside/Downside: +20.4%
• Consensus Rating: Hold
• Rating Score (0-4): 2.25
• Research Coverage: 16 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.99)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$200.32 million
• Net Margins: -7.13%
• Pretax Margin: -7.33%
• Return on Equity: -12.15%
• Return on Assets: -5.83%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.83
• Quick Ratio: 0.81

Sales & Book Value

• Annual Sales: $2.53 billion
• Price / Sales: 0.45
• Cash Flow: $1.79 per share
• Price / Cash Flow: 3.50
• Book Value: $7.81 per share
• Price / Book: 0.80

Miscellaneous

• Outstanding Shares: 181,680,000
• Free Float: 180,412,000
• Market Cap: $1.14 billion
• Optionable: Optionable
• Beta: 2.12